Turkish Version of Digital Eye Strain Questionnaire (DESQ)
Validity and Reliability of the Turkish Version of Digital Eye Strain Questionnaire (DESQ)
1 other identifier
observational
130
1 country
1
Brief Summary
The aims of this study were to perform cultural adaptation of the DESQ and provide information regarding the factor structure, reliability and validity of the instrument in Turkish speaking adults.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 20, 2023
CompletedFirst Posted
Study publicly available on registry
September 26, 2023
CompletedStudy Start
First participant enrolled
October 30, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedOctober 15, 2024
October 1, 2024
9 months
September 20, 2023
October 11, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
DESQ
Digital Eye Strain Questionnaire (DESQ) is a thirteen-item self-report scale in a yes-no format designed to offer a measure of complaints related to digital eye strain syndrome (DES)
Baseline and after 7 days
Interventions
Cross-cultural Adaptation, Reliability and Validity of the Turkish Version of the DESQ
Eligibility Criteria
Healthy adults who spend two or more continuous hours a day on their digital devices (computer, tablet, smartphone) or use more than one device
You may qualify if:
- Between the ages of 18-65 years
- People who spend two or more continuous hours a day on their digital devices (computer, tablet, smartphone) or use more than one device
You may not qualify if:
- History of ophthalmic surgery or active ocular disease
- Participants who did not understand the instructions or did not sign a consent form were excluded
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Alanya Alaadin Keykubat University
Antalya, 07425, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof.
Study Record Dates
First Submitted
September 20, 2023
First Posted
September 26, 2023
Study Start
October 30, 2023
Primary Completion
July 30, 2024
Study Completion
December 1, 2024
Last Updated
October 15, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share